TITLE

Conjugate Pneumococcal Vaccine and Adults

AUTHOR(S)
Deresinski, Stan
PUB. DATE
July 2012
SOURCE
Internal Medicine Alert;7/29/2012, Vol. 34 Issue 14, p109
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Synopsis: While Prevnar 13 has received FDA approval for use in adults aged 50 years and older, the CDC recommends continued use of the 23-valent polysaccharide pneumococcal vaccine until further information becomes available.
ACCESSION #
78394135

 

Related Articles

  • Acambis Wins FDA Approval For New Smallpox Vaccine. Moran, Nuala // BioWorld International;9/5/2007, Vol. 12 Issue 36, p1 

    The article reports that the U.S. Food and Drug Administration (FDA) has approved Acambis plc's smallpox vaccine ACAM 2000. The vaccine is the first new biodefense vaccine to be licensed since the U.S. government launched Project Bioshield in 2001. Acambis CEO Ian Garland claims that the...

  • health flash.  // Self;Apr2007, Vol. 29 Issue 4, p162 

    The article offers newsbriefs related to health in the U.S. The Centers for Disease Control and Prevention advised to scrub hands with soap and water for at least 20 seconds to remove germs and dirts while a new study from the Harvard School of Public Health discovers that nicotine content in...

  • First I.V. neuraminidase inhibitor approved to treat influenza. TANZI, MARIA G. // Pharmacy Today;Feb2015, Vol. 21 Issue 2, p38 

    The article focuses on the approval of BioCryst Pharmaceuticals Inc.'s peramivir (Rapivab) by the U.S. Food and Drug Administration (FDA). The drug is for the treatment of acute uncomplicated influenza in adult patients who have not been symptomatic for more than 2 days. Information about...

  • FDA Moves Quickly on Narcan Nasal Spray.  // NoDak Pharmacy;Dec2015, Vol. 28 Issue 5, p14 

    The article discusses the approval of the Narcan nasal spray by the U.S. Food and Drug Administration (FDA). Topics discussed include a report from the U.S. Centers for Disease Control and Prevention on rise in number of drug overdose deaths in the U.S., the views of FDA's acting commissioner...

  • Conjugate Pneumococcal Vaccine and Adults. Deresinski, Stan // Infectious Disease Alert;Jul2012, Vol. 31 Issue 10, p116 

    While Prevnar 13 has received FDA approval for use in adults aged 50 years and older, the cDc recommends continued use of the 23-valent polysaccharide pneumococcal vaccine until further information becomes available.

  • Updated Recommendations for Pneumococcal Vaccination of Adults. Deresinski, Stan // Infectious Disease Alert;Oct2010, Vol. 30 Issue 1, p4 

    The article discusses research being done on invasive pneumococcal disease among adults using 23-valent pneumococcal polysaccharide vaccine (PPSV23). It references a study conducted by the U.S. Centers for Disease Control Prevention (CDC), published in the 2010 issue of "Morbidity and Mortality...

  • Hemispherx Files Ampligen NDA: First Therapy For CFS? Osborne, Randall // BioWorld Today;10/12/2007, Vol. 18 Issue 199, p1 

    The article reports on the filing of a new drug application by Hemispherx Biopharma Inc. for Ampligen that could lead to the first approved toll-like receptor-based therapy and the first drug cleared by the U.S. Food & Drug Administration for chronic fatigue syndrome (CFS). The condition was...

  • Eye on Washington.  // Contemporary Pediatrics;Sept2003, Vol. 20 Issue 9, p12 

    Presents information on government regulations and programs on child care and pediatrics in the U.S. in 2003. Overview of the Pediatrics Research Equity Act passed by the U.S. Senate; Background on a joint initiative by the U.S. Centers for Disease Control and Prevention and the Autism Society...

  • Pre-exposure prophylaxis for HIV prevention under review by Food and Drug Administration.  // Contraceptive Technology Update;Jul2012 STI Quarterly, p1 

    The article reports on a 2012 decision which the U.S. Food and Drug Administration made to approve the drug Truvada, in conjunction with condoms and other safe sex measures, for the prevention of HIV in individuals at risk of acquiring the virus through sexual activity.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics